Elevated insular glutamate in fibromyalgia is associated with experimental pain.
Elevated insular glutamate in fibromyalgia is associated with experimental pain.
复制标题
DOI:
10.1002/art.24849
复制
发表时间:
2009-10
影响因子:
--
通讯作者:
Clauw, Daniel J.
中科院分区:
文献类型:
--
作者:
Harris, Richard E.;Sundgren, Pia C.;Craig, A. D.;Kirshenbaum, Eric;Sen, Ananda;Napadow, Vitaly;Clauw, Daniel J.
Central pain augmentation resulting from enhanced excitatory and/or decreased inhibitory neurotransmission is a proposed mechanism underlying the pathophysiology of functional pain syndromes such as fibromyalgia (FM). Multiple functional magnetic resonance imaging (fMRI) studies implicate the insula as a region of heightened neuronal activity in this condition. Since glutamate (Glu) is a major cortical excitatory neurotransmitter that functions in pain neurotransmission, we hypothesized that increased levels of insular Glu would be present in FM patients and that the concentration of this molecule would be correlated with pain report. 19 FM patients and 14 age- and sex-matched pain free controls underwent pressure pain testing and a proton magnetic resonance spectroscopy (H-MRS) session wherein the right anterior and right posterior insula were examined at rest. FM patients had significantly higher levels of Glu (mean(SD): FM 8.09(0.72); HC 6.86(1.29); p=0.009) and combined glutamate and glutamine (e.g. Glx; mean(SD): FM 12.38(0.94); HC 10.59(1.48); p=0.001) within the right posterior insula as compared to controls. No differences were detected in any of the other major metabolites within this region (all p>0.05) and no group differences were detected for any metabolite within the right anterior insula (all p>0.10). Within the right posterior insula, higher levels of Glu and Glx were associated with lower pressure pain thresholds across both groups (Glu: r=−0.43; p=0.012; Glx: r=−0.50; p=0.003). Enhanced glutamatergic neurotransmission resulting from higher concentrations of Glu within the posterior insula may play a role in the pathophysiology of FM and other central pain augmentation syndromes.
登录
查看更多内容
影响因子:
4.9
作者:
Peres, MFP;Zukerman, E;Faulhaber, MHW
通讯作者:
Faulhaber, MHW
影响因子:
4
作者:
Cohen, Steven P.;Verdolin, Michael H.;Mao, Jianren
通讯作者:
Mao, Jianren
影响因子:
7.4
作者:
Larson, AA;Giovengo, SL;Michalek, JE
通讯作者:
Michalek, JE
影响因子:
1.7
作者:
Vitton, O;Gendreau, M;Rao, SG
通讯作者:
Rao, SG
影响因子:
3.3
作者:
Hurd, R;Sailasuta, N;Nelson, SJ
通讯作者:
Nelson, SJ